SEC Form 4 · accession 0001179110-16-017357
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Youssef El Zein
Director · 10% Owner
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2016 | A | 3,608 | $3.00 | A | 500,528 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This stock was issued to the reporting person pursuant to his election under the Issuer's director compensation program in lieu of cash.